Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

NDR2 acts as the upstream kinase of ARK5 during insulin-like growth factor-1 signaling.

Suzuki A, Ogura T, Esumi H.

J Biol Chem. 2006 May 19;281(20):13915-21. Epub 2006 Feb 17.

2.

Regulation of caspase-6 and FLIP by the AMPK family member ARK5.

Suzuki A, Kusakai G, Kishimoto A, Shimojo Y, Miyamoto S, Ogura T, Ochiai A, Esumi H.

Oncogene. 2004 Sep 16;23(42):7067-75.

PMID:
15273717
3.

Regulation of NDR2 protein kinase by multi-site phosphorylation and the S100B calcium-binding protein.

Stegert MR, Tamaskovic R, Bichsel SJ, Hergovich A, Hemmings BA.

J Biol Chem. 2004 May 28;279(22):23806-12. Epub 2004 Mar 22.

4.

Strong association of ARK5 with tumor invasion and metastasis.

Kusakai G, Suzuki A, Ogura T, Kaminishi M, Esumi H.

J Exp Clin Cancer Res. 2004 Jun;23(2):263-8.

PMID:
15354411
5.

3'-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling.

Storz P, Toker A.

Front Biosci. 2002 Apr 1;7:d886-902. Review.

PMID:
11897568
6.

ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.

Suzuki A, Iida S, Kato-Uranishi M, Tajima E, Zhan F, Hanamura I, Huang Y, Ogura T, Takahashi S, Ueda R, Barlogie B, Shaughnessy J Jr, Esumi H.

Oncogene. 2005 Oct 20;24(46):6936-44.

PMID:
16044163
7.

Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein.

Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, Lavin MF, Esumi H.

J Biol Chem. 2003 Jan 3;278(1):48-53. Epub 2002 Oct 29.

8.

Human Mob proteins regulate the NDR1 and NDR2 serine-threonine kinases.

Devroe E, Erdjument-Bromage H, Tempst P, Silver PA.

J Biol Chem. 2004 Jun 4;279(23):24444-51. Epub 2004 Apr 2.

9.

ARK5 is a tumor invasion-associated factor downstream of Akt signaling.

Suzuki A, Lu J, Kusakai G, Kishimoto A, Ogura T, Esumi H.

Mol Cell Biol. 2004 Apr;24(8):3526-35.

10.

The Mycobacterium tuberculosis serine/threonine kinase PknL phosphorylates Rv2175c: mass spectrometric profiling of the activation loop phosphorylation sites and their role in the recruitment of Rv2175c.

Canova MJ, Veyron-Churlet R, Zanella-Cleon I, Cohen-Gonsaud M, Cozzone AJ, Becchi M, Kremer L, Molle V.

Proteomics. 2008 Feb;8(3):521-33. doi: 10.1002/pmic.200700442.

PMID:
18175374
11.

IGF-I regulated phosphorylation and translocation of PDK-1 in neurons.

Alajajian BB, Fletcher L, Isgor E, Jimenez DF, Digicaylioglu M.

Neuroreport. 2009 Apr 22;20(6):579-83. doi: 10.1097/WNR.0b013e328329a41a.

PMID:
19276999
12.

A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo.

Ji QS, Mulvihill MJ, Rosenfeld-Franklin M, Cooke A, Feng L, Mak G, O'Connor M, Yao Y, Pirritt C, Buck E, Eyzaguirre A, Arnold LD, Gibson NW, Pachter JA.

Mol Cancer Ther. 2007 Aug;6(8):2158-67. Epub 2007 Aug 1.

13.

Novel functions of the phospholipase D2-Phox homology domain in protein kinase Czeta activation.

Kim JH, Kim JH, Ohba M, Suh PG, Ryu SH.

Mol Cell Biol. 2005 Apr;25(8):3194-208.

15.

Activation loop phosphorylation-independent kinase activity of human protein kinase C zeta.

Ranganathan S, Wang Y, Kern FG, Qu Z, Li R.

Proteins. 2007 May 15;67(3):709-19.

PMID:
17335005
16.

Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells.

Baumann P, Mandl-Weber S, Emmerich B, Straka C, Schmidmaier R.

Exp Cell Res. 2007 Oct 1;313(16):3592-603. Epub 2007 Jul 4.

PMID:
17669398
17.

Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.

Vasilcanu R, Vasilcanu D, Sehat B, Yin S, Girnita A, Axelson M, Girnita L.

Mol Pharmacol. 2008 Mar;73(3):930-9. Epub 2007 Dec 10.

18.

IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.

Borowiec AS, Hague F, Harir N, Guénin S, Guerineau F, Gouilleux F, Roudbaraki M, Lassoued K, Ouadid-Ahidouch H.

J Cell Physiol. 2007 Sep;212(3):690-701.

PMID:
17520698
19.

The last five amino acid residues at the C-terminus of PRK1/PKN is essential for full lipid responsiveness.

Lim WG, Zhu Y, Wang CH, Tan BJ, Armstrong JS, Dokland T, Yang H, Zhu YZ, Teo TS, Duan W.

Cell Signal. 2005 Sep;17(9):1084-97. Epub 2005 Jan 26.

PMID:
15993750
20.

Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.

Ravid D, Chuderland D, Landsman L, Lavie Y, Reich R, Liscovitch M.

Exp Cell Res. 2008 Sep 10;314(15):2762-73. doi: 10.1016/j.yexcr.2008.06.004. Epub 2008 Jun 12.

PMID:
18598695

Supplemental Content

Support Center